Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.
作者信息
Zou Shi, Wu Mengmeng, Ming Fangzhao, Wu Songjie, Guo Wei, Marley Gifty, Xing Zhongyuan, Zhang Zhiyue, Zeng Minxia, Sun Chao, Zhang Jianfeng, Tang Weiming, Liang Ke
机构信息
Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wuchang District Center for Disease Control and Prevention, Wuhan, China.
出版信息
AIDS Res Ther. 2024 Sep 23;21(1):63. doi: 10.1186/s12981-024-00655-y.
Abstract
摘要
相似文献
1
Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.更正：新型冠状病毒灭活疫苗的免疫反应及安全性：HIV感染者与未感染HIV个体的比较
AIDS Res Ther. 2024 Sep 23;21(1):63. doi: 10.1186/s12981-024-00655-y.
2
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.免疫应答和安全性：感染 HIV 人群与 HIV 阴性人群接种新冠灭活疫苗的比较
AIDS Res Ther. 2022 Jul 5;19(1):33. doi: 10.1186/s12981-022-00459-y.
3
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China.中国HIV感染者中新型冠状病毒灭活疫苗的安全性和免疫原性
Infect Drug Resist. 2022 Apr 21;15:2091-2100. doi: 10.2147/IDR.S353127. eCollection 2022.
4
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.在 HIV-1 感染者和非感染者中，SARS-CoV-2 重组刺突蛋白纳米颗粒疫苗的免疫原性和安全性：一项随机、对照、2A/2B 期试验。
Lancet HIV. 2022 May;9(5):e309-e322. doi: 10.1016/S2352-3018(22)00041-8.
5
Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China.中国HIV感染者中新冠病毒灭活疫苗加强针的安全性和免疫原性
Vaccines (Basel). 2023 May 23;11(6):1019. doi: 10.3390/vaccines11061019.
6
Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.在感染 HIV 的人群中使用灭活的 SARS-CoV-2 疫苗的免疫原性和安全性：一项纵向队列研究。
J Med Virol. 2023 Dec;95(12):e29334. doi: 10.1002/jmv.29334.
7
Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China.比较中国 HIV 感染者和 HIV 阴性个体对 SARS-CoV-2 灭活疫苗的免疫反应：一项横断面研究。
Viruses. 2022 Jan 28;14(2):277. doi: 10.3390/v14020277.
8
Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV.在感染 HIV 的人群中，第 3 个月时对灭活 COVID-19 疫苗的体液免疫反应。
BMC Infect Dis. 2023 Jan 20;23(1):34. doi: 10.1186/s12879-023-07982-x.
9
COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity.中国艾滋病毒感染者（PLWH）的COVID-19疫苗接种：一项关于疫苗犹豫、安全性和免疫原性的横断面研究。
Vaccines (Basel). 2021 Dec 9;9(12):1458. doi: 10.3390/vaccines9121458.
10
Covid-19 vaccine immunogenicity in people living with HIV-1.Covid-19 疫苗在 HIV-1 感染者中的免疫原性。
Vaccine. 2022 Jun 9;40(26):3633-3637. doi: 10.1016/j.vaccine.2022.04.090. Epub 2022 May 5.
本文引用的文献
1
Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals.免疫应答和安全性：感染 HIV 人群与 HIV 阴性人群接种新冠灭活疫苗的比较
AIDS Res Ther. 2022 Jul 5;19(1):33. doi: 10.1186/s12981-022-00459-y.
Zotero 插件